Study on Hormone Replacement Therapy and Blood Clot Risks

Overview of Hormone Replacement Therapy

Researchers from the UK have conducted a comprehensive study examining the relationship between various types of hormone replacement therapy (HRT) and the risk of blood clots. HRT is commonly prescribed to alleviate symptoms associated with menopause, including night sweats, hot flashes, and mood swings. However, recent guidelines from the National Institute for Health and Care Excellence (NICE) suggest that there is insufficient information regarding the risks and benefits of HRT.

Types of Hormone Replacement Therapy

Hormone replacement therapy can take multiple forms, with the primary aim of replenishing hormones that diminish during menopause. These therapies may involve estrogen alone or a combination of estrogen and progesterone. The delivery methods vary, including tablets, gels, creams, or patches.

Previous Research on Blood Clot Risks

Prior studies have indicated a potential increase in the risk of blood clots, specifically venous thromboembolism, among women undergoing HRT. Blood clots can migrate to various body parts, leading to complications that range from mild to severe. However, the NICE report highlighted a significant lack of data, preventing healthcare professionals from making definitive recommendations regarding the use of HRT.

Current Research Findings

To fill this knowledge gap, UK researchers analyzed the medical records of thousands of women with a history of blood clots, publishing their findings in the British Medical Journal. They compared records of over 80,000 women who experienced blood clots with those of similar-aged women without such a history. The analysis focused on the types of hormone replacement therapy used, such as tablets, gels, creams, and patches.

Association Between Tablets and Blood Clot Risk

The study revealed that women who experienced blood clots were more likely to have used hormone replacement therapy. Notably, women utilizing HRT in tablet form had double the likelihood of developing blood clots compared to those who did not use HRT. The formulation of the hormone also influenced the risk, with no increased danger associated with patches, creams, or gels. The researchers concluded that these latter forms of HRT are the safest options.

Implications for Women’s Health

Interestingly, the participants in the study showed a lower usage rate of gels, creams, and patches. The researchers emphasized the importance of their findings, suggesting that the results could inform future guidelines, enabling women and their healthcare providers to make well-informed treatment decisions.

References

Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. Bmj. 2018;364:k4810. doi:10.1136/bmj.k4810.
Eurekalert. The global source for science news. https://www.eurekalert.org/pub_releases/2019-01/uon-hti010719.php Last accessed: February 8, 2019.

Related Topics

– What are the Effects of Progesterone on Heart Disease in Hormone Therapy?
– Hormone Replacement Calculator
– Hormone Replacement Therapy and Cancer: What’s the Link?
– Does Hormone Replacement Therapy Increase the Risk of Blood Clots?
– Is Thyroid Hormone Replacement Therapy Necessary for Hypothyroidism?